Success Metrics

Clinical Success Rate
96.7%

Based on 29 completed trials

Completion Rate
97%(29/30)
Active Trials
0(0%)
Results Posted
31%(9 trials)
Terminated
1(3%)

Phase Distribution

Ph phase_2
5
14%
Ph not_applicable
2
6%
Ph phase_3
6
17%
Ph phase_4
7
20%
Ph phase_1
9
26%

Phase Distribution

9

Early Stage

5

Mid Stage

13

Late Stage

Phase Distribution29 total trials
Phase 1Safety & dosage
9(31.0%)
Phase 2Efficacy & side effects
5(17.2%)
Phase 3Large-scale testing
6(20.7%)
Phase 4Post-market surveillance
7(24.1%)
N/ANon-phased studies
2(6.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

96.7%

29 of 30 finished

Non-Completion Rate

3.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

35

all time

Status Distribution
Active(1)
Completed(29)
Terminated(1)
Other(4)

Detailed Status

Completed29
unknown4
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
35
Active
0
Success Rate
96.7%
Most Advanced
Phase 4

Trials by Phase

Phase 19 (31.0%)
Phase 25 (17.2%)
Phase 36 (20.7%)
Phase 47 (24.1%)
N/A2 (6.9%)

Trials by Status

not_yet_recruiting13%
unknown411%
completed2983%
terminated13%

Recent Activity

Clinical Trials (35)

Showing 20 of 35 trialsScroll for more
NCT07351773Not Applicable

Ultrasound-Guided Stellate Ganglion Block for Alzheimer's Disease

Completed
NCT05078944Not Applicable

Progress of Mild Alzheimer's Disease in Participants on Acupuncture Versus Sham Acupuncture

Completed
NCT06828289

Rivastigmine Mini-Tablet for Alzheimer's Disease

Not Yet Recruiting
NCT05709301Phase 2

Randomized Clinical Trial of Donepezil for the Treatment of Mild Cognitive Impairment in Parkinson's Disease

Unknown
NCT01251718

Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease

Completed
NCT00688376Phase 3

Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment

Completed
NCT00165724Phase 4

Alzheimer's Disease Long-term Follow-up Study (ALF Study)

Completed
NCT00477659Phase 4

Neural Correlates In Mild Alzheimer's Disease

Completed
NCT00369785Phase 3

Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors

Completed
NCT01466270Phase 2

Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction

Completed
NCT00070161Phase 2

Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor

Completed
NCT04013477Phase 1

Single-ascending Dose Phase 1 Clinical Trial to Evaluate the Safety and PK of DA-5207 TDS in Healthy Adults

Completed
NCT03073876Phase 4

Detecting an Early Response to Donepezil With Measures of Visual Attention

Completed
NCT02660983Phase 4

A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease

Completed
NCT03907371Phase 2

The Effect of Donepezil in Radiotherapy-related Cognitive Impairment.

Unknown
NCT01129596

Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-

Completed
NCT02162251

Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease

Completed
NCT02162264

Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice

Completed
NCT02448784

Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).

Completed
NCT03151382Phase 4

A Based on PEEG and PET Study of Anxiolytic Treatment to Improve Cognitive Function in Patients With Alzheimer Disease

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
35